Keyword: Active Pharmaceutical Ingredients (APIs)

News

Olon Expands API Production

26.05.2023 -

Olon, an Italian CDMO and API producer, is investing a total of €100 million in 2023 to increase production capacity, in particular at its site in Mulazzano, Lodi...

News

Wacker Buys All of ADL BioPharma from Private Equity

11.05.2023 -

German chemical group Wacker has acquired 100% of ADL Biopharma from private equity investor Kartesia for a price said to exceed €100 million. It now owns the entire 150...

News

IMCD Seals Two Acquisitions and a Distribution Deal

09.05.2023 -

Rotterdam-based speciality chemicals distributor IMCD kicked off the month of May agreeing a major distribution partnership and two outright acquisitions.

News

Glenmark Putting Chunk of API Offshoot up for Sale?

02.05.2023 -

India-headquartered drugmaker Glenmark is said to be taking another look at selling a majority stake in its business with active pharmaceutical ingredients (APIs), which...

Strategy & Management

Containment Solutions for HPAPI Manufacturing

21.03.2023 -

Clear incentive for drug manufacturers to equip their production facilities with the capacity to process highly potent active pharmaceutical ingredients (HPAPIs). HPAPIs...

News

US Uncovers Covid-related Bogus API-making Deals

03.03.2023 -

Under US president Joe Biden, the Department of Justice has been moving energetically of late to uncover and prosecute offenses that might otherwise have been swept under...

News

Veranova Completes API Expansion at Edinburgh

14.02.2023 -

Macfarlan Smith, a UK-based unit of US API maker Veranova, formerly known as Johnson Matthey Health, has completed a $10 million expansion of its mid-scale active...

Plant Construction & Process Technology

Curiosity, Disillusionment, Persistence, Success

07.12.2022 -

Given the challenges the pharmaceutical industry is facing – secure material supply, reduce operation cost and increase flexibility, enhance sustainability and safety...